BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36740682)

  • 1. p53 aberration and TFE3 gene amplification may be predictors of adverse prognosis in epithelioid angiomyolipoma of the kidney.
    Zhang Y; Wei X; Teng X; Chen G
    Diagn Pathol; 2023 Feb; 18(1):14. PubMed ID: 36740682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A renal epithelioid angiomyolipoma/perivascular epithelioid cell tumor with TFE3 gene break visualized by FISH.
    Ohe C; Kuroda N; Hes O; Michal M; Vanecek T; Grossmann P; Tanaka Y; Tanaka M; Inui H; Komai Y; Matsuda T; Uemura Y
    Med Mol Morphol; 2012 Dec; 45(4):234-7. PubMed ID: 23224603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulator of interferon genes (STING) immunohistochemical expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney.
    Caliò A; Brunelli M; Gobbo S; Pedron S; Segala D; Argani P; Martignoni G
    Pathology; 2021 Aug; 53(5):579-585. PubMed ID: 33461798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PSF/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity.
    Rao Q; Shen Q; Xia QY; Wang ZY; Liu B; Shi SS; Shi QL; Yin HL; Wu B; Ye SB; Li L; Chen JY; Pan MH; Li Q; Li R; Wang X; Zhang RS; Yu B; Ma HH; Lu ZF; Zhou XJ
    Am J Surg Pathol; 2015 Sep; 39(9):1181-96. PubMed ID: 26274027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunohistochemical study of perivascular epithelioid cell neoplasms].
    Xia QY; Rao Q; Shen Q; Liu B; Li L; Shi QL; Shi SS; Yu B; Zhang RS; Ma HH; Lu ZF; Wang X; Tu P; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2013 Jun; 42(6):381-5. PubMed ID: 24060071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A distinctive subset of PEComas harbors TFE3 gene fusions.
    Argani P; Aulmann S; Illei PB; Netto GJ; Ro J; Cho HY; Dogan S; Ladanyi M; Martignoni G; Goldblum JR; Weiss SW
    Am J Surg Pathol; 2010 Oct; 34(10):1395-406. PubMed ID: 20871214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perivascular epithelioid cell tumor (PEComa) with TFE3 gene rearrangement: clinicopathological, immunohistochemical, and molecular features.
    Shen Q; Rao Q; Xia QY; Yu B; Shi QL; Zhang RS; Zhou XJ
    Virchows Arch; 2014 Nov; 465(5):607-13. PubMed ID: 25239799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. t(6;11) renal cell carcinoma: a study of seven cases including two with aggressive behavior, and utility of CD68 (PG-M1) in the differential diagnosis with pure epithelioid PEComa/epithelioid angiomyolipoma.
    Caliò A; Brunelli M; Segala D; Pedron S; Tardanico R; Remo A; Gobbo S; Meneghelli E; Doglioni C; Hes O; Zampini C; Argani P; Martignoni G
    Mod Pathol; 2018 Mar; 31(3):474-487. PubMed ID: 29052596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding the histomorphologic spectrum of TFE3-rearranged perivascular epithelioid cell tumors.
    Maloney N; Giannikou K; Lefferts J; Bridge JA; Linos K
    Hum Pathol; 2018 Dec; 82():125-130. PubMed ID: 29626599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant perivascular epithelioid cell neoplasm (PEComa) of the urinary bladder with TFE3 gene rearrangement: clinicopathologic, immunohistochemical, and molecular features.
    Williamson SR; Bunde PJ; Montironi R; Lopez-Beltran A; Zhang S; Wang M; Maclennan GT; Cheng L
    Am J Surg Pathol; 2013 Oct; 37(10):1619-26. PubMed ID: 23797724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic angiomyolipomas may overexpress TFE3, but have no relevant genetic alterations.
    Jimbo N; Nishigami T; Noguchi M; Iijima H; Hirota S; Tajiri T; Inoue T; Hirose T; Itoh T; Zen Y
    Hum Pathol; 2017 Mar; 61():41-48. PubMed ID: 27865795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TFE3 translocation-associated perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: morphology, immunophenotype, differential diagnosis.
    Schoolmeester JK; Dao LN; Sukov WR; Wang L; Park KJ; Murali R; Hameed MR; Soslow RA
    Am J Surg Pathol; 2015 Mar; 39(3):394-404. PubMed ID: 25517951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathologic Characterization of Bladder Perivascular Epithelioid Cell Neoplasms (PEComa): A Series of 11 Cases With a Subset Having TFE3 Rearrangements.
    Neumann NM; Haffner MC; Argani P; Kao CS; Epstein JI
    Am J Surg Pathol; 2021 Feb; 45(2):169-177. PubMed ID: 33002920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TFE3 activation in a TSC1-altered malignant PEComa: challenging the dichotomy of the underlying pathogenic mechanisms.
    Schmiester M; Dolnik A; Kornak U; Pfitzner B; Hummel M; Treue D; Hartmann A; Agaimy A; Weyerer V; Lekaj A; Brakemeier S; Peters R; Öllinger R; Märdian S; Bullinger L; Striefler JK; Flörcken A
    J Pathol Clin Res; 2021 Jan; 7(1):3-9. PubMed ID: 33180365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NONO::TFE3 fusion cutaneous epithelioid and spindle cell tumor: A case series.
    See SHC; Olivares S; Kulkarni M; Dhillon SK; Fumero-Velazquez MS; Hagstrom MNE; Gerami P
    J Cutan Pathol; 2023 Nov; 50(11):956-962. PubMed ID: 37606377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanotic Xp11 translocation renal cancers: a distinctive neoplasm with overlapping features of PEComa, carcinoma, and melanoma.
    Argani P; Aulmann S; Karanjawala Z; Fraser RB; Ladanyi M; Rodriguez MM
    Am J Surg Pathol; 2009 Apr; 33(4):609-19. PubMed ID: 19065101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parvalbumin immunohistochemical expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney.
    Caliò A; Ammendola S; Brunelli M; Pedron S; Gobbo S; Martignoni G
    Virchows Arch; 2021 Apr; 478(4):785-791. PubMed ID: 32524185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant perivascular epithelioid cell tumor of the oropharynx with strong TFE3 expression mimicking alveolar soft part sarcoma: a case report and review of the literature.
    Saluja K; Thomas J; Zhang S; Sturgis EM; Jain KS; Prieto VG; El-Naggar AK; Bell D
    Hum Pathol; 2018 Jun; 76():149-155. PubMed ID: 29208563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TFE3-Expressing Epithelioid Rich Perivascular Epithelioid Cell Neoplasm (PEComa) of the Bladder with Unusual Benign Course.
    Chen XF; Yeong J; Chang KTE; Lim AST; Kuick CH; Lim TH; Sudhanshi J; Selvarajan S; Gan VHL; Khor LY
    Ann Clin Lab Sci; 2018 Jan; 48(1):110-115. PubMed ID: 29531006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perivascular epithelioid cell tumor with SFPQ/PSF-TFE3 gene fusion in a patient with advanced neuroblastoma.
    Tanaka M; Kato K; Gomi K; Matsumoto M; Kudo H; Shinkai M; Ohama Y; Kigasawa H; Tanaka Y
    Am J Surg Pathol; 2009 Sep; 33(9):1416-20. PubMed ID: 19606011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.